Gilead to buy Immunomedics for $21bn
14-09-2020
Gilead signs deal to license new cancer treatment
02-09-2020
Gilead continues oncology expansion with Tizona deal
22-07-2020
China approves three Gilead remdesivir patents for COVID-19 treatment
27-02-2020
Gilead fails to have US government patents invalidated
21-02-2020